Optimi Health is starting a clinical trial to evaluate psilocybin-assisted therapy for Major Depressive Disorder.
The trial is in Phase 2, indicating it has moved beyond initial safety testing.
Key Takeaways
Center
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Get every side of the week's biggest story in your inbox.
Potential new treatment for Major Depressive Disorder
No attributed perspective yet — we only show quotes grounded in analysis.
Evaluated across 1 reporting source (0% Left · 100% Center · 0% Right)
Historical editorial baseline for The Manila Times
Multi-factor accuracy index for The Manila Times and related desks based on verifiable sourcing and editorial standards.
Factuality: High 100%
Ownership: The Manila Times (Corporate)
Public conversation related to this story
Loading comments…